NVCA executive calls biotech one bright spot in “otherwise sleepy” IPO market

NVCACiting biotechnology as the one bright spot. the President and Chief Executive Officer of the National Venture Capital Association describes the initial public offering market as “otherwise sleepy” for venture fund-backed entities. Read his views and citations here.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.